FDA Approved: NILOTINIB — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for a generic nilotinib product. The generic is intended to treat certain Philadelphia chromosome-posi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

ORIG AP for NILOTINIB (NILOTINIB)